Adoption Barriers for Continuous Glucose Monitoring and Their Potential Reduction With a Fully Implanted System: Results From Patient Preference Surveys. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

Adoption Barriers for Continuous Glucose Monitoring and Their Potential Reduction With a Fully Implanted System: Results From Patient Preference Surveys.

Robert Engler, Timothy L Routh, Joseph Y Lucisano

Author Information

Robert Engler: University of California, San Diego, School of Medicine, San Diego, CA.
Timothy L Routh: GlySens, Inc., San Diego, CA.
Joseph Y Lucisano: GlySens, Inc., San Diego, CA.

PMID: 29382979 DOI: 10.2337/cd17-0053

A patient-centered approach to device design can provide important advantages in optimizing diabetes care technology for broadened adoption and improved adherence. Results from two surveys of people with diabetes and the parents of children with diabetes ( = 1,348) regarding continuous glucose monitoring (CGM) devices reveal the importance of the concept of "user burden" in patients' and caregivers' evaluations of the acceptability of available devices. Survey respondents' strongly favorable reactions to a proposed 1-year, fully implanted CGM device with no skin-attached components further confirm that minimizing system obtrusiveness will likely be of significant value in reducing hurdles to CGM device use and adherence.

Diabetes Care. 2005 May;28(5):1231-9 [PMID: 15855600]
Diabetes Care. 2015 Jun;38(6):971-8 [PMID: 25998289]
Diabetes Care. 2016 Dec;39(12 ):2126-2140 [PMID: 27879358]
J Diabetes Sci Technol. 2015 Mar;9(2):320-30 [PMID: 25555391]
N Engl J Med. 2008 Oct 2;359(14):1464-76 [PMID: 18779236]
Diabet Med. 2015 May;32(5):609-17 [PMID: 25661981]
Diabetes Care. 2010 Jan;33(1):17-22 [PMID: 19837791]
Diabetes Care. 2009 Nov;32(11):1947-53 [PMID: 19675206]
Diabetes Care. 2014 Oct;37(10):2702-9 [PMID: 25011947]
Clin Diabetes. 2017 Jan;35(1):60-65 [PMID: 28144048]
Am Psychol. 2016 Oct;71(7):577-589 [PMID: 27690486]
Diabetes Care. 2014;37(1):9-16 [PMID: 24356592]
J Diabetes Sci Technol. 2015 Sep 09;10 (2):383-8 [PMID: 26353781]
Diabetes Care. 2011 Apr;34(4):795-800 [PMID: 21335621]
Diabetes Care. 2017 Feb;40(2):181-187 [PMID: 27899489]
Diabetes Care. 2016 Jun;39(6):e81-2 [PMID: 27208319]
Diabetes Care. 2016 May;39(5):686-93 [PMID: 26861924]
Diabetes Technol Ther. 2016 Feb;18 Suppl 2:S3-S13 [PMID: 26784127]
Diabetes Technol Ther. 2016 Mar;18(3):115-7 [PMID: 26983025]
Diabetologia. 2012 Dec;55(12):3155-62 [PMID: 22965294]
N Engl J Med. 1993 Sep 30;329(14 ):977-86 [PMID: 8366922]
Diabetes Technol Ther. 2016 Mar;18(3):127-35 [PMID: 26950530]
Diabetes Care. 2010 Jun;33(6):1269-74 [PMID: 20332354]
J Diabetes Sci Technol. 2013 May 01;7(3):789-94 [PMID: 23759412]
J Med Econ. 2016;19(3):236-42 [PMID: 26510389]
Diabetes Care. 2009 Aug;32(8):1378-83 [PMID: 19429875]
Diabetologia. 2016 Sep;59(9):1795-805 [PMID: 27364997]
J Clin Endocrinol Metab. 2011 Oct;96(10):2968-79 [PMID: 21976745]

Journal Article

Performance of subcutaneously implanted glucose sensors for continuous monitoring.Fully integrated flexible biosensor for wearable continuous glucose monitoring.Toward an agent-based patient-physician model for the adoption of continuous glucose monitoring technology.Continuous glucose monitoring system for congenital hyperinsulinemia.Updated Psychosocial Surveys With Continuous Glucose Monitoring Items for Youth With Type 1 Diabetes and Their Caregivers.Preterm Glycosuria - New Data from a Continuous Glucose Monitoring System.Toward a continuous intravascular glucose monitoring system.Fully Disposable Wireless Patch Sensor for Continuous Remote Patient Monitoring.[Continuous monitoring of subcutaneous glucose concentration using implanted enzyme electrodes].Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study.

Providing Point-of-Care Sample CGM Increases Uptake of Personal CGM.A Prospective Multicenter Clinical Performance Evaluation of the C-CGM System.Improving Continuous Glucose Monitoring Use in Emerging Adults With Type 1 Diabetes.Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry Study.First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes.Accuracy of a Seventh-Generation Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes.Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.A Prospective Pilot Study Demonstrating Noninvasive Calibration-Free Glucose Measurement.User requirements for non-invasive and minimally invasive glucose self-monitoring devices in low-income and middle-income countries: a qualitative study in Kyrgyzstan, Mali, Peru and Tanzania.Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator.

See all "Cited by" articles